Eli Lilly became the first drugmaker to reach a $1 trillion market valuation on Friday, driven by the rapid growth of its ...

Eli Lilly has made history by becoming the first healthcare company to reach a $1 trillion market cap, thanks to the success ...

Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by ...

Eli Lilly becomes the first healthcare firm to hit $1T, powered by GLP-1 dominance, surging sales, and strong investor ...

While heart disease, diabetes and prediabetes are the most common health concerns related to obesity, many other conditions ...

Eli Lilly hit a $1 trillion valuation for the first time, becoming the only healthcare company to reach the milestone as ...

Orforglipron is Lilly’s oral GLP-1 in phase 3 development as a treatment for diabetes and obesity. The FDA is expected to approve the drug in March 2026. Lilly’s November news release states that the ...

Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by ...

Eli Lilly has made history by becoming the first healthcare company in the world to reach a staggering $1 trillion market capitalization, a milestone typically reserved for tech giants. This ...